Arthur Becker: an Early Stage Bio-Tech Expert and a Real Estate Guru

Arthur Becker is a New York-based real estate investor and an early stage Bio Tech enthusiast. Mr. Becker attended the Bennington College from the year 1969 to 1972, graduating with a Bachelor of Arts degree. He later joined Amos Tuck School of Business at Dartmouth for a business course.

Career Development.

Arthur Becker started working as a partner at a motion pictures company. He later joined Bear Stearns Inc. where he worked at their client services department. His amicable performance in creating an investment clientele base prompted his promotion to the position of Director. Arthur later worked at ProGroup Inc., a company that supplied golf equipment as a Board of Director’s Chairman. In 1994, Arthur founded Bnox, A firm that developed and distributed affordable cameras and binoculars. Arthur returned to photography in the late 90s, and his work was exhibited at Morgan Walker Fine Art, the Hal Katzen in New York, Art Basel and Arcuture Fine Art in Palm Beach Florida.

Arthur Establishes Atlantic Investors

In 2001, Arthur together with a partner founded Atlantic Investors that acquired three companies, including Navisite Inc. Arthur was put in charge of NaviSite, a company that provided Internet solutions as the CEO. He held that position until 2010 and remained as a board member until 2011. While still at Navisite, Arthur worked at Vera Wang Group in the Finance and Operations Division and also acted as a senior advisor to the company for seven years, reveals perezhilton.com.

Also see, http://pagesix.com/2013/02/21/vera-wang-opens-up-on-breakdown-of-marriage/.

Arthur at Zinio

In 2012, Arthur Becker joined Zinio, LLC as the Chairman and CEO, a position he held for three years. Mr. Becker gathered extensive knowledge in technology and real estate in the course of his stay at Navisite and Zinio. This experience merged with his exposure to early stage Biotech companies instilled an interest to start his business, Madison Partners, LLC, an early stage biotechnology and an investment company with a focus in real estate. Arthur has invested in a number of biotech innovations that include Acetylon, which he later sold to Celgene and a cancer vaccine technology named Oncopep among others. In a report by therealdeal.com, he currently engages in developing residential houses in Miami and New York.